These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25863762)

  • 1. Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays.
    van Nimwegen FA; Cutter DJ; Schaapveld M; Rutten A; Kooijman K; Krol AD; Janus CP; Darby SC; van Leeuwen FE; Aleman BM
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):153-60. PubMed ID: 25863762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold.
    Petersen PM; Aznar MC; Berthelsen AK; Loft A; Schut DA; Maraldo M; Josipovic M; Klausen TL; Andersen FL; Specht L
    Acta Oncol; 2015 Jan; 54(1):60-6. PubMed ID: 25025999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: a step toward understanding dose risk for late toxicity.
    Ng A; Brock KK; Sharpe MB; Moseley JL; Craig T; Hodgson DC
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e557-63. PubMed ID: 22929861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
    Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
    Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
    Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
    Hahn E; Jiang H; Ng A; Bashir S; Ahmed S; Tsang R; Sun A; Gospodarowicz M; Hodgson D
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1116-1123. PubMed ID: 28721895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.
    van Nimwegen FA; Ntentas G; Darby SC; Schaapveld M; Hauptmann M; Lugtenburg PJ; Janus CPM; Daniels L; van Leeuwen FE; Cutter DJ; Aleman BMP
    Blood; 2017 Apr; 129(16):2257-2265. PubMed ID: 28143884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma.
    Maraldo MV; Brodin NP; Vogelius IR; Aznar MC; Munck Af Rosenschöld P; Petersen PM; Specht L
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1232-7. PubMed ID: 22270170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines.
    Abbassi LM; Goudjil F; Arsène-Henry A; Dendale R; Kirova YM
    Cancer Radiother; 2019 Dec; 23(8):922-925. PubMed ID: 31257097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?
    Aznar MC; Maraldo MV; Schut DA; Lundemann M; Brodin NP; Vogelius IR; Berthelsen AK; Specht L; Petersen PM
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):169-74. PubMed ID: 25754634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Substructure Segmentation and Dosimetry Using a Novel Hybrid Magnetic Resonance and Computed Tomography Cardiac Atlas.
    Morris ED; Ghanem AI; Pantelic MV; Walker EM; Han X; Glide-Hurst CK
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):985-993. PubMed ID: 30468849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.
    van Nimwegen FA; Schaapveld M; Cutter DJ; Janus CP; Krol AD; Hauptmann M; Kooijman K; Roesink J; van der Maazen R; Darby SC; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2016 Jan; 34(3):235-43. PubMed ID: 26573075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma.
    Maraldo MV; Jørgensen M; Brodin NP; Aznar MC; Vogelius IR; Petersen PM; Berthelsen AK; Christensen CB; Hjalgrim LL; Specht L
    Pediatr Blood Cancer; 2014 Apr; 61(4):717-22. PubMed ID: 24660228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
    Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
    Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.
    Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
    Ann Oncol; 2013 Aug; 24(8):2113-8. PubMed ID: 23619032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy.
    Pinnix CC; Gunther JR; Fang P; Bankston ME; Milgrom SA; Boyce D; Lee HJ; Nair R; Steiner R; Strati P; Ahmed S; Iyer SP; Westin J; Parmar S; Rodriguez MA; Nastoupil L; Neelapu S; Flowers C; Dabaja BS
    JAMA Netw Open; 2020 Sep; 3(9):e2013935. PubMed ID: 32990738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method to estimate doses to the normal tissues after past extended and involved field radiotherapy for Hodgkin lymphoma.
    Maraldo MV; Lundemann M; Vogelius IR; Specht L
    Radiother Oncol; 2015 Feb; 114(2):206-11. PubMed ID: 25620063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.